Drug-Induced Liver Injury

Area of Science:

• Hepatology
• Toxicology
• Internal Medicine

Background:

• Drug-induced liver injury (DILI) encompasses a range of liver damage.
• DILI can manifest in various phenotypic presentations and histological patterns.
• While some DILI patterns are predictable with common medications, idiosyncratic reactions are unpredictable and non-dose-dependent.

Purpose of the Study:

• To outline the classification of DILI phenotypes and injury patterns.
• To discuss diagnostic criteria for DILI.
• To review therapeutic interventions and management strategies for DILI.

Main Methods:

• Review of existing literature on DILI classification and diagnosis.
• Analysis of diagnostic criteria for DILI phenotype.
• Examination of therapeutic approaches for managing DILI patients.

Main Results:

• DILI exhibits a spectrum of liver injuries with identifiable phenotypes and patterns.
• Diagnostic criteria aid in classifying DILI phenotypes.
• Therapeutic interventions focus on patient support and may include liver transplantation.

Conclusions:

• Understanding DILI phenotypes and injury patterns is crucial for diagnosis.
• Standardized diagnostic criteria improve DILI classification.
• Comprehensive management, including supportive care and transplantation, is vital for DILI patients.